Literature DB >> 20680522

Down-regulation of miR-126 expression in colorectal cancer and its clinical significance.

Xiang-Min Li1, Ai-Min Wang, Juan Zhang, Hong Yi.   

Abstract

MicroRNAs (miRNAs) are non-coding RNAs that regulate the expression of target mRNAs. Altered expression of specific miRNAs in several tumor types has been reported. However, the expression levels of miR-126 in colorectal cancers are unclear. In this study, we compared the expression of miR-126 between colorectal cancer tissues and non-tumor tissues. The expression levels of miR-126 in colorectal cancer tissues were significantly lower than those in non-tumor tissues, and miR-126 overexpression inhibited the growth of colorectal cancer cells. This new information may help to clarify the molecular mechanisms involved in colorectal carcinogenesis and to indicate that miR-126 may be a novel suppressive microRNA and help to differentiate between malignant and normal colorectal tissue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20680522     DOI: 10.1007/s12032-010-9637-6

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  11 in total

Review 1.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

2.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

3.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

4.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo.

Authors:  Bo Liu; Xiao-Chun Peng; Xiao-Li Zheng; Jun Wang; Yong-Wen Qin
Journal:  Lung Cancer       Date:  2009-02-14       Impact factor: 5.705

6.  Differentially expressed microRNAs in small cell lung cancer.

Authors:  Edit Miko; Zsolt Czimmerer; Eszter Csánky; Gábor Boros; Júlia Buslig; Balázs Dezso; Beáta Scholtz
Journal:  Exp Lung Res       Date:  2009-10       Impact factor: 2.459

Review 7.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

Review 8.  Colorectal cancer screening: scientific review.

Authors:  Judith M E Walsh; Jonathan P Terdiman
Journal:  JAMA       Date:  2003-03-12       Impact factor: 56.272

9.  Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.

Authors:  Xiaohong Wang; Shuang Tang; Shu-Yun Le; Robert Lu; Janet S Rader; Craig Meyers; Zhi-Ming Zheng
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

10.  Breast cancer metastasis: a microRNA story.

Authors:  Massimo Negrini; George Adrian Calin
Journal:  Breast Cancer Res       Date:  2008-03-26       Impact factor: 6.466

View more
  36 in total

1.  Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.

Authors:  Tong Zhou; Guangjun Zhang; Zuoliang Liu; Shusen Xia; Hongpeng Tian
Journal:  Int J Colorectal Dis       Date:  2012-07-07       Impact factor: 2.571

2.  Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.

Authors:  Zeng Li; Nan Li; Minghua Wu; Xiayu Li; Zhaohui Luo; Xiaoyan Wang
Journal:  Mol Cell Biochem       Date:  2013-06-07       Impact factor: 3.396

3.  Down-regulation of tissue microRNA-126 was associated with poor prognosis in patients with cutaneous melanoma.

Authors:  Nengxing Lin; Yu Zhou; Xin Lian; Yating Tu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint.

Authors:  Alexandru V Olaru; Gabriel Ghiaur; Sumitaka Yamanaka; Delgermaa Luvsanjav; Fangmei An; Irinel Popescu; Sorin Alexandrescu; Sarah Allen; Timothy M Pawlik; Michael Torbenson; Christos Georgiades; Lewis R Roberts; Gregory J Gores; Anne Ferguson-Smith; Maria I Almeida; George A Calin; Esteban Mezey; Florin M Selaru
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

5.  Fenretinide reduces angiogenesis by downregulating CDH5, FOXM1 and eNOS genes and suppressing microRNA-10b.

Authors:  Elif Isil Yücel; Mehmet Sahin
Journal:  Mol Biol Rep       Date:  2020-01-10       Impact factor: 2.316

6.  Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification.

Authors:  Ghada Al-Kafaji; Harun Muayad Said; Mahmood Abduljalil Alam; Ziad Tarraq Al Naieb
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

7.  Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.

Authors:  Ze-wu Li; Yong-mei Yang; Lu-tao Du; Zhaogang Dong; Li-li Wang; Xin Zhang; Xuan-jun Zhou; Gui-xi Zheng; Ai-lin Qu; Chuan-xin Wang
Journal:  Med Oncol       Date:  2014-10-01       Impact factor: 3.064

8.  Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K).

Authors:  Yoshihiro Ito; Jonathan R Hart; Lynn Ueno; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

9.  miR-126: A novel regulator in colon cancer.

Authors:  Weina Huang; Jie Lin; Hongxuan Zhang
Journal:  Biomed Rep       Date:  2015-12-02

10.  Evaluation of the Expression Level and Hormone Receptor Association of miR-126 in Breast Cancer.

Authors:  Maedeh Rouigari; Moein Dehbashi; Hossein Tabatabaeian; Kamran Ghaedi; Parisa Mohammadynejad; Mansoureh Azadeh
Journal:  Indian J Clin Biochem       Date:  2018-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.